NuVasive Brand Guidelines: San Diego, 1997, the XLIF Lateral Approach & a Globus Merger

A spine company built around access.

NuVasive was incorporated in San Diego, California, on 21 July 1997, English Wikipedia says, as a medical device company focused on minimally invasive spine surgery. Its approach rested on a surgical platform it called Maximum Access Surgery, or MAS, and on one procedure in particular: XLIF, short for eXtreme Lateral Interbody Fusion.

The idea behind XLIF, as English Wikipedia describes it, is direction. Instead of reaching the spine from the front or the back of the body, the surgeon reaches the space between two vertebrae from the side. NuVasive built a business around that procedure and the things that go with it: software for surgical planning and monitoring, access instruments and implantable hardware.

English Wikipedia lists the conditions those products were made to help treat, from degenerative disc disease and lumbar spinal stenosis to early-onset scoliosis and limb-length discrepancy. In the United States and abroad, most of the products were marketed directly to doctors, hospitals and other healthcare facilities, and the company focused on integrated systems for what it called its surgeon partners.

By the time of its merger the company reported in three segments, English Wikipedia says: Spine; Orthopedics, under the name NuVasive Specialized Orthopedics; and Neuromonitoring, through NuVasive Clinical Services. It also ran a patient-support programme called The Better Way Back and a charitable arm, the NuVasive Spine Foundation, which English Wikipedia says provides equipment, surgical support and funds to people who need spine surgery around the world.

Acquisitions, materials and a factory in Ohio.

NuVasive also grew by acquisition. English Wikipedia lists Ellipse Technologies and Biotronic NeuroNetwork in 2016, Vertera Spine and SafePassage in 2017, and Simplify Medical in 2021. It also took on the LessRay product from SafeRay Spine and launched it in 2018 as a fluoroscopy system that enhances the clarity of X-ray images taken during surgery.

The Vertera deal shows the company’s interest in materials. Healio reported on 7 September 2017 that NuVasive had acquired Vertera Spine, a maker of porous PEEK products, and that through the deal NuVasive was reportedly the only medical device company to offer porous technology for both PEEK and titanium. Gregory T. Lucier, then chairman and chief executive, said in the company’s release that NuVasive “takes the next step in building out its advanced materials science technology.”

Manufacturing moved in-house over the same decade. In May 2013, English Wikipedia says, NuVasive bought ANC, a small manufacturer in Fairborn, Ohio, as a first step towards making its own spinal devices. That led to a larger plant in West Carrollton, Ohio; all manufacturing moved there in early 2018, and the in-house parts maker is known as NuVasive Manufacturing. English Wikipedia puts its workforce at roughly 300 by 2024.

So NuVasive, based in San Diego, made its own spinal devices in Ohio, while its three business segments covered spine, specialised orthopaedics and the neuromonitoring used during surgery, English Wikipedia says.

The category.

Orthopaedic device makers sell to a narrow, expert audience: surgeons, theatre teams, hospital buyers and the distributors who serve them. Their brand material is shaped by that audience. Product imagery tends to be precise and technical, with implants rendered as clean metallic objects, often lit against dark or neutral backgrounds so that the form of a stem, a plate or a screw reads clearly.

Clinical imagery sits alongside the renders. X-rays, bone models, anatomical cut-aways and diagrams of a joint or a spinal segment show where a device goes and how it is meant to fit. Many makers also photograph surgeons in theatre, in gowns and masks under surgical lights, and show the trays of instruments that accompany an implant system, laid out in rows that suggest order and completeness.

Education is a large part of the picture. Device makers run training courses, cadaver labs and online technique guides, and much of their visual output is instructional: step-by-step surgical technique documents, animations and videos. Congresses matter too. Large meetings such as the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) and the congress of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT) are where new systems are often shown, on stands designed to carry a brand at scale.

Corporate identities in the field are usually restrained: sans-serif wordmarks, a small set of brand colours and a great deal of white space, with the visual drama left to the product and the clinical image. Many brands also sit inside larger groups, so a single name may appear alongside a parent company’s mark. That makes the typeface, the palette and the treatment of imagery the main tools a maker has for being recognised.

From independent company to part of Globus.

NuVasive’s independence ended in 2023. Its merger with Globus Medical of Audubon, Pennsylvania, was completed on 1 September 2023, English Wikipedia says, and ORTHOWORLD reported the completion that week, describing a combined offering of spine and orthopaedic procedures and enabling technologies. NuVasive is now part of Globus Medical and no longer trades as an independent company. The XLIF family appears on Globus’s own website, which says XLIF has helped to shape minimally invasive surgery “for over 20 years” and lists versions including XLIF Thoracic, XLIF Corpectomy and a lateral single-position approach.

The naming system has kept growing there. Globus describes XLIF Lateral SPS, its lateral single-position surgery, as a combination of three procedural solutions — XLIF, XALIF and XFixation — performed with the patient lying on one side, and presents XLIF ACR as an alternative to conventional posterior approaches. The X of NuVasive’s lateral fusion procedure now runs through a Pennsylvania company’s catalogue.

The name has also been in the news in Japan. The Asahi Shimbun reported in December 2025 that NuVasive Japan had acknowledged that four of its sales representatives operated X-ray machines during spinal-implant surgeries at hospitals in the Kanto and Kansai regions between April and November 2024, work that Japanese law reserves for physicians and licensed radiological technologists. The company issued a public apology in November 2025, and police searched its Tokyo headquarters that month. In May 2026 the paper reported that Osaka prefectural police were investigating a suspected violation of the Radiology Technicians Law, and that NuVasive Japan declined to comment while the investigation continued.

As a brand, NuVasive was built around a procedure as much as a product. Its names — MAS, XLIF, The Better Way Back — described a way of operating and a route for patients, and the lateral approach has continued under its new owner.

For a design guide, NuVasive shows how a procedure name can carry a brand further than a company name. Compare Globus Medical, which now owns it, and Medtronic, the Minneapolis device maker. For this guide we use a Pacific slate, a sea green and sand with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep NuVasive’s identity on hand — save it to a board in the Made Good inspiration library.